Svenska English

Careligo

Clinical Evidence

Clinical evaluations of OPTILOGG

Randomized, controlled trial (PACEMAN-HF), n= 82, Karolinska Hospital, Södersjukhuset, Danderyd's Hospital, 2014
2.7 in-hospital days less per patient after 6 months, a 28% reduction, (RR: 0.72, 95% CI: 0.61-0.84; p<0.05)
30% better self-care behavior (EHFScB) or an improvement by 7 points, (IG: 16.5 [IQR: 12; 22] vs. CG: 23.5 [IQR 18.8; 30.0], p<0.05)
29% higher health-related quality of life (KCCQ), (IG: 72.7 [IQR: 50.8; 87.9] vs. CG: 51.8 [IQR 40.9; 62.8], p<0.05)
12% relative improvement in knowledge about heart failure (DHFKS), (p<0.05)
85% system compliance (daily use of OPTILOGG), (IQR: 71%; 93%)
Link to abstract (pdf)
Citations:
Hägglund et al., 2015, Scand Card J, ”Patient-centred home-based management of heart failure” (ID 1035319 DOI:3109/141731.2015.1035319)
Melin et al., 2014, European Heart Journal (2014 ) 35 ( Abstract Supplement ), 838, “Patient Centered Management of Heart Failure - results of a randomized controlled study - the PACEMAN-HF study.”

Randomized, controlled trial, n= 100, Hemse Health Central (primary care setting), Gotland, 2015
33% fewer in-hospital days per patient after 6 months (RR: 0.67; 95% CI: 0.45-0.99; p<0.05)
45% improvement in self-care behavior (EHFScB), corresponding to a 14 points improvement (longitudinal test), (Baseline: 31 [IQR: 28; 35] vs. 6 months: 17 [IQR 14; 25], p<0.05)
97% system complaice (daily use of OPTILOGG), (IQR: 91%; 99%)
Link to abstract (pdf)
Citations:
Hovland et al., 2016, European Journal of Heart Failure (2016) 18 (Suppl. 1), p.55, P256, "PACEMAN-HF - pooled analysis from two randomized controlled trials"

Meta-analys of PACEMAN-HF and Hemse: pooled, adjusted analysis, n= 172, 2016
29,2% reduction of in-hospital days per patient after 6 months (RR: 0.708; 95% CI: 0.607-0.825; p<0.05)
94% system compliance (daily use of OPTILOGG), (IQR: 84%; 98%)
Link to abstract (pdf)
Citations:
Hovland et al., 2016, European Journal of Heart Failure (2016) 18 (Suppl. 1), p.55, P256, "PACEMAN-HF - pooled analysis from two randomized controlled trials"

Matched, controlled intervention study, n= 62, Norrtälje Hospital (Vårdbolaget tio100 AB), Norrtälje, 2017
36% reduction of in-hospital days per patient after 9 months, (RR: 0.64; 95% CI: 0.47-0.87; p<0.05)
Link to abstract (pdf)
Citations:
Blomqvist et al., 2017, European Journal of Heart Failure (2017) 19 (Suppl. S1), p.459, P1847, "Evaluation of e-health tool for heart failure patients", DOI: 10.1002/ejhf.833